Clinical Journal of the American Society of Nephrology (CJASN)
by American Society of Nephrology
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 4 chart positions in 4 markets.
By chart position
- 🇳🇬NG · Medicine#105500 to 3K
- 🇹🇼TW · Medicine#146500 to 3K
- 🇨🇱CL · Medicine#151500 to 3K
- 🇬🇷GR · Medicine#194500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1K to 6K🎙 Weekly cadence·199 episodes·Last published 2w ago - Monthly Reach
Unique listeners across all episodes (30 days)
2K to 12K🇳🇬25%🇹🇼25%🇨🇱25%+1 more - Active Followers
Loyal subscribers who consistently listen
600 to 3.6K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 11 epsHosts
Not detected.
Recent guests
Recent episodes
Trends in Vascular Access Placement
Aug 21, 2026
Unknown duration
High-Volume Hemodiafiltration vs. Hemodialysis? New Data on Survival in Incident End-Stage Kidney Disease
Jul 22, 2026
Unknown duration
A Target Trial Emulation of GLP1RA, SGLT2i or DPP4i as Add on Treatment in CKD
Jun 17, 2026
5m 28s
Total Kidney Volume and eGFR in Polycystic Kidney Disease
May 18, 2026
3m 54s
Proteomic Markers of Dietary Patterns and Chronic Kidney Disease
Apr 16, 2026
4m 50s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 8/21/26 | Trends in Vascular Access Placement | In this podcast, Dr. Allon and Dr. Lee summarize the main findings from their study on "Trends in Vascular Access Placement among Patients Initiating Hemodialysis with a Catheter" on behalf of their colleagues. | — | ||||||
| 7/22/26 | High-Volume Hemodiafiltration vs. Hemodialysis? New Data on Survival in Incident End-Stage Kidney Disease | Drs. Ficociello, Zhang, & Kalantar-Zadeh summarize the main findings from their study, "Hemodialysis Modality and Mortality Outcomes among Incident Dialysis Patients: An International Cohort Study Comparing High-Volume Hemodiafiltration and Hemodialysis." | — | ||||||
| 6/17/26 | CKDGLP1RA+4 | Dr. RoumieDr. Hung | American Society of NephrologyTarget Emulation Trial: GLP1RA, SGLT2i, DPP4i for Kidney Outcome Prevention | — | CKDGLP1RA+4 | — | 5m 28s | ||
| 5/18/26 | kidney diseasepolycystic kidney disease+3 | Dr. Yu | American Society of NephrologyRelationship between Total Kidney Volume and eGFR in Autosomal Dominant Polycystic Kidney Disease | — | kidney volumeeGFR+3 | — | 3m 54s | ||
| 4/16/26 | dietary patternschronic kidney disease+4 | Dr. Rebholz | American Society of NephrologyProteomic Markers of Dietary Patterns, CKD Progression, and Mortality in the CRIC Study | — | proteomic markersdietary patterns+4 | — | 4m 50s | ||
| 3/18/26 | clinical trialnephrology+3 | Dr. Saland | LumasiranILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1 | Primary Hyperoxaluria Type 1 | ILLUMINATE-ALumasiran+3 | — | 3m 54s | ||
| 2/26/26 | finerenoneeGFR slope+3 | Dr. McCausland | FINEARTS-HF | — | finerenoneeGFR+3 | — | 3m 00s | ||
| 2/18/26 | kidney transplantgraft failure+3 | Dr. ParikhDr. Malhotra+1 | American Society of NephrologyDynamic Risk Prediction of Graft Failure After Deceased Donor Kidney Transplant | — | kidney transplantgraft failure+5 | — | 4m 06s | ||
| 12/18/25 | pediatric nephrologyperitoneal dialysis+3 | Dagmara Borzych-DużałkaKhandelval | International Pediatric Peritoneal Dialysis Network | — | icodextrinperitoneal dialysis+3 | — | 6m 20s | ||
| 10/28/25 | chronic kidney diseaselubiprostone+3 | Dr. Sumida | American Society of NephrologyComparative Effectiveness of Lubiprostone and Stool Softeners on Risk of Kidney Outcomes in Patients with CKD | — | CKDlubiprostone+3 | — | 3m 53s | ||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 9/30/25 | SGLT2 inhibitionchronic kidney disease+3 | Dr. Neuen | American Society of NephrologySGLT2 inhibition and hospitalizations in patients with CKD: Data from CREDENCE and a meta-analysis of CKD progression trials | — | SGLT2chronic kidney disease+4 | — | 3m 47s | ||
| 8/27/25 | kidney outcomesC3 glomerulopathy+3 | Dr. Ghaddar | American Society of NephrologyClinical and Histologic Predictors of Kidney Outcomes in C3 Glomerulopathy and Idiopathic Membranoproliferative Glomerulonephritis | — | kidneyglomerulopathy+3 | — | 3m 09s | ||
| 7/25/25 | nephrologyfellowship+3 | Drs. RaslanDr. Triozzi | American Society of NephrologyAssessing Current Nephrology Fellows' Perceptions of Future Earnings as Attending Physicians | — | nephrology fellowsfuture earnings+3 | — | 3m 03s | ||
| 6/27/25 | SGLT2 Inhibitors and Risk of Urinary Tract Infections with Abnormal Genitourinary Pathology | In this podcast, Drs. Eadon, Zhang, and Xu summarize the main findings from their study on "Risk of Urinary Tract Infections with SGLT2 Inhibitors in Subpopulations with Abnormal Genitourinary Pathology" on behalf of their colleagues. | — | ||||||
| 4/23/25 | Transition Practices in Pediatric and Adult Nephrology | In this podcast, Dr. Vissing summarizes the main findings from his study on "Bridging the Gap: Assessing Nephrology Transition Practices in Pediatric and Adult Medical Centers" on behalf of his colleagues. | — | ||||||
| 3/25/25 | Creatinine and Cystatin-Based Equations in People with Cancer | In this podcast, Dr. Titan summarizes the main findings from her study on "Performance of creatinine and cystatin-based equations on estimating measured GFR in people with hematological and solid cancers" on behalf of her colleagues. | — | ||||||
| 2/14/25 | GLP1 Receptor Agonists and Kidney Outcomes | In this podcast, Dr. Mendonça summarizes the main findings from his study on "The Impact of Glucagon-like Peptide-1 Receptor Agonists on Kidney Outcomes: A Meta-Analysis of Randomized Placebo-Controlled Trials" on behalf of his colleagues. | — | ||||||
| 1/23/25 | Anticoagulation and Fracture Risk in CKD Patients with Atrial Fibrillation | In this podcast, Drs. Khan and Paik summarize the main findings from their study on "Fracture in association with anticoagulant therapy in patients with chronic kidney disease and atrial fibrillation" on behalf of their colleagues. | — | ||||||
| 12/23/24 | Comparing USRDS vs. National Death Index on Sudden Cardiac Death in Dialysis Patients | In this podcast, Dr. Shafi and Dr. Obi summarize the main findings from their study on "Comparing USRDS and National Death Index Data on Sudden Cardiac Death in US Dialysis Patients" on behalf of their colleagues. | — | ||||||
| 11/26/24 | Association of Kidney Function with SGLT2 Inhibitor Discontinuation | In this podcast, Dr. Estrella summarizes the main findings from her study on "Association of kidney function with SGLT2 inhibitor discontinuation among United States Veterans" on behalf of her colleagues. | — | ||||||
| 11/15/24 | Interview with 2024 CJASN Trainee of the Year – Second Place Awardee: Dr. Mohammad Azfar Qureshi | In this podcast, CJASN Editor-in-Chief Dr. Rhee interviewed Dr. Qureshi on the findings of his study "The Association of Intra-abdominal Adhesions with Peritoneal Dialysis Catheter-Related Complications." | — | ||||||
| 11/14/24 | Interview with 2024 CJASN Trainee of the Year – First Place Awardee: Dr. Christine Limonte | In this podcast, CJASN Editor-in-Chief Dr. Rhee interviewed Dr. Limonte on the findings of her study "Associations of Biomarkers of Tubular Injury and Inflammation with Biopsy Features in Type 1 Diabetes." | — | ||||||
| 10/21/24 | Providers' Experiences Discussing Alternatives to Kidney Replacement Therapy with Patients | In this podcast, Drs. Wong and Chotivatanapong summarize the main findings from their study on "Nephrology Providers' Experiences Discussing Care for Patients with Kidney Failure who Forgo Kidney Replacement Therapy: National Qualitative Study" | — | ||||||
| 9/23/24 | Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management | CJASN editors highlight three articles centered on the theme of CKD, including articles on SGLT2 inhibitors in CKD patients; SGLT2 inhibitors and cardiovascular death in CKD; and smartphone intervention for lifestyle and hypertension management in CKD. | — | ||||||
| 8/16/24 | Fellows' Perspectives on Parental Leave Policies and Family Planning | In this podcast, Dr. Kendrick and Dr. Dixon summarize the main findings from their study on "A National Survey of Pregnancy and Parenthood Among Nephrology Trainees: A Focus on Nephrology Fellowship" on behalf of their colleagues. | — | ||||||
Showing 25 of 204
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Clinical Journal of the American Society of Nephrology (CJASN)
Peaked at #105 in NG, currently #105 in NG.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| NG | — | #105 | #105 | — |
| TW | — | #146 | #146 | — |
| CL | — | #151 | #151 | — |
| GR | — | #194 | #194 | — |
Chart Positions
4 placements across 4 markets.
Chart Positions
4 placements across 4 markets.